Is Tonix Pharmaceuticals (TNXP) All Set To Hit New Highs?

One of the pharmaceutical stocks to have come into focus over the past weeks is that of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and considering the sort of gains it has made, it could be worthwhile to look at it a bit more closely.

Is Tonix Pharmaceuticals (TNXP) All Set To Hit New Highs?

The Tonix stock has made significant gains over the course of the past six weeks and delivered gains of as much as 150% during the period. On Thursday, the stock made further gains in premarket trading. The rally in the stock on Thursday was triggered by online speculation with regards to a status update from the United States Patent and Trademark Office with the tag ‘Notice of Allowance Mailed’.

The patent in question has the company and its Chief Executive Officer Seth Lederman inventors. It should be noted that the company filed for a patent for its product TNX-102 SL which is meant for treating agitation and psychosis among others. It might be worthwhile for investors to keep their eyes peeled about further developments regarding Tonix.

Is Tonix Pharmaceuticals (TNXP) All Set To Hit New Highs?

Anthony Gonzales

Biotech, Tech, and Crypto reporterAnthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.